{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:26Z","timestamp":1786982246251,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Beijing Municipal Science and Technology Commission Fund","award":["Z171100001017181"],"award-info":[{"award-number":["Z171100001017181"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12072-020-10088-0","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T09:02:46Z","timestamp":1599210166000},"page":"788-797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (\u2264\u20095\u00a0cm): a propensity score analysis"],"prefix":"10.1007","volume":"14","author":[{"given":"Jing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xian","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ze","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Zhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Zhang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"10088_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"B Freddie","year":"2018","unstructured":"Freddie B, Jacques F, Isabelle S, Rebecca LS, Lindsey AT, Ahmedin J. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10088_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000475768","volume":"6","author":"ZC Zeng","year":"2017","unstructured":"Zeng ZC, Seong J, Yoon SM, Cheng JC, Lam KO, Lee AS, et al. Consensus on stereotactic body radiation therapy for small-sized hepatocellular carcinoma at the 7th Asia-Pacific primary liver cancer expert meeting. Liver cancer. 2017;6(4):264\u201374.","journal-title":"Liver cancer"},{"issue":"4","key":"10088_CR3","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/j.ijrobp.2011.04.011","volume":"81","author":"DL Andolino","year":"2011","unstructured":"Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, et al. Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2011;81(4):e447\u2013e45353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10088_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"Liver EAFTSOT","year":"2012","unstructured":"Liver EAFTSOT. EASL\u2013EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908\u201343.","journal-title":"J Hepatol"},{"issue":"2","key":"10088_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the american association for the study of liver diseases. Hepatology. 2018;68(2):723\u201350.","journal-title":"Hepatology"},{"issue":"4","key":"10088_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/hepr.12359","volume":"45","author":"T Kimura","year":"2015","unstructured":"Kimura T, Aikata H, Takahashi S, Takahashi I, Nishibuchi I, Doi Y, et al. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies. Hepatol Res. 2015;45(4):378\u201386.","journal-title":"Hepatol Res"},{"issue":"5","key":"10088_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/hepr.12383","volume":"45","author":"N Sanuki","year":"2015","unstructured":"Sanuki N, Takeda A, Oku Y, Eriguchi T, Nishimura S, Aoki Y, et al. Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma. Hepatol Res. 2015;45(5):540\u20137.","journal-title":"Hepatol Res"},{"issue":"2","key":"10088_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jso.24128","volume":"113","author":"TS Su","year":"2016","unstructured":"Su TS, Liang P, Lu HZ, Liang J, Gao YC, Zhou Y, et al. Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients. J Surg Oncol. 2016;113(2):181\u20137.","journal-title":"J Surg Oncol"},{"issue":"1","key":"10088_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/bjs.9960","volume":"103","author":"GA Kim","year":"2016","unstructured":"Kim GA, Shim JH, Kim MJ, Kim SY, Won HJ, Shin YM, et al. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas. Br J Surg. 2016;103(1):126\u201335.","journal-title":"Br J Surg"},{"issue":"5","key":"10088_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","volume":"34","author":"DR Wahl","year":"2016","unstructured":"Wahl DR, Stenmark MH, Tao Y, Pollom EL, Caoili EM, Lawrence TS, et al. Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma. J Clin Oncol. 2016;34(5):452\u20139.","journal-title":"J Clin Oncol"},{"key":"10088_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jhep.2020.03.005","volume":"73","author":"N Kim","year":"2020","unstructured":"Kim N, Cheng J, Jung I, Liang J, Shih YL, Huang WY, et al. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma. J Hepatol. 2020;73:121\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.005.","journal-title":"J Hepatol."},{"issue":"8","key":"10088_CR12","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37(8):4078\u2013101.","journal-title":"Med Phys"},{"issue":"5","key":"10088_CR13","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jaad.2012.02.010","volume":"67","author":"AP Chen","year":"2012","unstructured":"Chen AP, Setser A, Anadkat MJ, Cotliar J, Olsen EA, Garden BC, et al. Grading dermatologic adverse events of cancer treatments: the common terminology criteria for adverse events version 4.0. J Am Acad Dermatol. 2012;67(5):1025\u201339.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10088_CR14","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0360-3016(94)00418-K","volume":"31","author":"TS Lawrence","year":"1995","unstructured":"Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31(5):1237.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10088_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.radonc.2010.10.014","volume":"98","author":"SX Liang","year":"2011","unstructured":"Liang SX, Huang XB, Zhu XD, Zhang WD, Cai L, Huang HZ, et al. Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh Grade A cirrhosis. Radiother Oncol. 2011;98(2):265\u20139.","journal-title":"Radiother Oncol"},{"issue":"2","key":"10088_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/hep.27745","volume":"62","author":"S Roayaie","year":"2015","unstructured":"Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L, et al. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology. 2015;62(2):440\u201351.","journal-title":"Hepatology"},{"issue":"8","key":"10088_CR17","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/bjs.11153","volume":"106","author":"N Takemura","year":"2019","unstructured":"Takemura N, Aoki T, Hasegawa K, Kaneko J, Arita J, Akamatsu N, et al. Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension. Br J Surg. 2019;106(8):1066\u201374.","journal-title":"Br J Surg"},{"issue":"5","key":"10088_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.surg.2015.04.002","volume":"158","author":"JL Qiu","year":"2015","unstructured":"Qiu JL, Zheng Y, Shen JX, Zeng QA, Zou RH, Liao YD, et al. Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: a propensity score matching study. Surgery. 2015;158(5):1235\u201343.","journal-title":"Surgery"},{"issue":"6","key":"10088_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach\u2014the ALBI grade. J Clin Oncol. 2015;33(6):550\u20138.","journal-title":"J Clin Oncol"},{"issue":"8","key":"10088_CR20","doi-asserted-by":"publisher","first-page":"e0182969","DOI":"10.1371\/journal.pone.0182969","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang L, Feng YM, Ma XW, Wang GC, Wu H, Xie XY, et al. Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis. PLoS ONE. 2017;12(8):e0182969.","journal-title":"PLoS ONE"},{"key":"10088_CR21","first-page":"1527","volume":"6","author":"Z Yuan","year":"2013","unstructured":"Yuan Z, Tian L, Wang P, Song Y, Dong Y, Zhuang H. Comparative research on the efficacy of CyberKnife\u00ae and surgical excision for stage I hepatocellular carcinoma. OncoTargets Ther. 2013;6:1527\u201332.","journal-title":"OncoTargets Ther"},{"issue":"3","key":"10088_CR22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ijrobp.2017.02.095","volume":"98","author":"TS Su","year":"2017","unstructured":"Su TS, Liang P, Liang J, Lu HZ, Jiang HY, Cheng T, et al. Long-term survival analysis of stereotactic ablative radiotherapy versus liver resection for small hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2017;98(3):639.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10088_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-016-0577-4","volume":"16","author":"SY Lee","year":"2017","unstructured":"Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, et al. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer. 2017;16(1):10.","journal-title":"Mol Cancer"},{"issue":"1","key":"10088_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1667\/RR14177.1","volume":"185","author":"Y Pan","year":"2016","unstructured":"Pan Y, Zhou CP, Yuan DX, Zhang JH, Shao CL. Radiation exposure promotes hepatocarcinoma cell invasion through epithelial mesenchymal transition mediated by H2S\/CSE pathway. Radiat Res. 2016;185(1):96\u2013105.","journal-title":"Radiat Res"},{"issue":"5","key":"10088_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.6004\/jnccn.2017.0059","volume":"15","author":"AB Benson","year":"2017","unstructured":"Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, et al. NCCN guidelines insights: hepatobiliary cancers, version 1.2017. J Natl Compr Cancer Netw. 2017;15(5):563\u201373.","journal-title":"J Natl Compr Cancer Netw"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10088-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-020-10088-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10088-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T23:02:23Z","timestamp":1630710143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-020-10088-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10088"],"URL":"https:\/\/doi.org\/10.1007\/s12072-020-10088-0","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"19 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective cohort study was approved by the Institutional Review Board of Beijing 302 Hospital (Beijing, China). Each patient fully understood treatment options (hepatic resection, liver transplantation, radio-frequency ablation, and CK-SBRT), and chose the treatment voluntarily before receiving any treatment in our medical center. The patient signed a consent after confirming his\/her treatment option and agreed to publish the results of a follow-up study on the treatment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}